Engineered Glibenclamide-Loaded Nanovectors Hamper Inflammasome Activation in an Ex Vivo Alzheimer's Disease Model—A Novel Potential Therapy for Neuroinflammation: A Pilot Study.

Saved in:
Bibliographic Details
Title: Engineered Glibenclamide-Loaded Nanovectors Hamper Inflammasome Activation in an Ex Vivo Alzheimer's Disease Model—A Novel Potential Therapy for Neuroinflammation: A Pilot Study.
Authors: La Rosa, Francesca1 (AUTHOR), Agostini, Simone1,2 (AUTHOR) sagostini@dongnocchi.it, Bolognesi, Elisabetta1,3 (AUTHOR), Marventano, Ivana1,4 (AUTHOR), Mancuso, Roberta1 (AUTHOR), Guerini, Franca Rosa1,2 (AUTHOR), Hernis, Ambra1,3 (AUTHOR), Citterio, Lorenzo Agostino1,4 (AUTHOR), Piancone, Federica1 (AUTHOR), Trimarchi, Pietro Davide1 (AUTHOR), Navarro, Jorge1 (AUTHOR), Rossetto, Federica1 (AUTHOR), Amenta, Arianna2 (AUTHOR), Seneci, Pierfausto2 (AUTHOR), Sesana, Silvia3 (AUTHOR), Re, Francesca3 (AUTHOR), Clerici, Mario1,4 (AUTHOR), Saresella, Marina1 (AUTHOR)
Source: Biomolecules (2218-273X). Aug2025, Vol. 15 Issue 8, p1074. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:2218273X
DOI:10.3390/biom15081074